Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,711,000 | 8,143,000 | 7,058,000 | 5,230,000 | 5,488,000 |
| Marketable Securities | 120,000 | 51,000 | 145,000 | 165,000 | 220,000 |
| Receivables | 16,335,000 | 15,153,000 | 15,169,000 | 14,815,000 | 14,831,000 |
| Inventories | 6,557,000 | 6,593,000 | 6,467,000 | 5,884,000 | 5,288,000 |
| Other current assets | 0 | 0 | 100,000 | 45,000 | 0 |
| TOTAL | $28,723,000 | $29,940,000 | $28,939,000 | $26,139,000 | $25,827,000 |
| Non-Current Assets | |||||
| PPE Net | 12,962,000 | 12,083,000 | 11,637,000 | 10,819,000 | 10,252,000 |
| Investments And Advances | 3,023,000 | 2,788,000 | 2,648,000 | 1,900,000 | 2,082,000 |
| Intangibles | 59,088,000 | 59,410,000 | 59,147,000 | 58,680,000 | 58,202,000 |
| Other Non-Current Assets | 10,278,000 | 10,235,000 | 10,051,000 | 8,715,000 | 7,672,000 |
| TOTAL | $85,351,000 | $84,516,000 | $83,483,000 | $80,114,000 | $78,208,000 |
| Total Assets | $114,074,000 | $114,456,000 | $112,422,000 | $106,253,000 | $104,035,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,104,000 | 6,174,000 | 6,492,000 | 3,403,000 | 2,337,000 |
| Accounts payable and accrued liabilities | 25,280,000 | 25,028,000 | 23,986,000 | 22,544,000 | 22,465,000 |
| Other current liabilities | 767,000 | 1,205,000 | 1,268,000 | 1,171,000 | 1,319,000 |
| TOTAL | $30,617,000 | $34,054,000 | $33,536,000 | $29,129,000 | $27,866,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,715,000 | 24,700,000 | 24,714,000 | 26,692,000 | 26,506,000 |
| Other Non-Current Liabilities | 6,515,000 | 6,125,000 | 5,749,000 | 5,748,000 | 5,486,000 |
| TOTAL | $34,738,000 | $34,431,000 | $34,076,000 | $35,993,000 | $35,298,000 |
| Total Liabilities | $65,355,000 | $68,485,000 | $67,612,000 | $65,122,000 | $63,164,000 |
| Shareholders' Equity | |||||
| Common Shares | 388,000 | 388,000 | 388,000 | 388,000 | 388,000 |
| Retained earnings | 10,972,000 | 8,213,000 | 7,023,000 | 3,364,000 | 3,160,000 |
| Other shareholders' equity | 2,093,000 | 2,127,000 | 2,161,000 | 2,146,000 | 2,097,000 |
| TOTAL | $48,719,000 | $45,971,000 | $44,810,000 | $41,131,000 | $40,871,000 |
| Total Liabilities And Equity | $114,074,000 | $114,456,000 | $112,422,000 | $106,253,000 | $104,035,000 |